Benzo(a)pyrene and 7,12-dimethylbenz(a)anthrecene differentially affect bone marrow cells of the lymphoid and myeloid lineages

作者: Noé Galván , Todd J. Page , Charles J. Czuprynski , Colin R. Jefcoate

DOI: 10.1016/J.TAAP.2005.09.018

关键词:

摘要: Polycyclic aromatic hydrocarbons (PAHs) are common environmental contaminants that carcinogenic and immunosuppressive. Benzo(a)pyrene (BP) 7,12-dimethylbenz(a)anthracene (DMBA) two prototypic PAHs known to impair the cell-mediated humoral immune responses. We have previously shown that, in C57BL/6J mice, total bone marrow (BM) cellularity decreased two-fold following intraperitoneal DMBA treatment but not BP treatment. Here, we used flow cytometry demonstrate differentially alter lymphoid myeloid lineages. Following treatment, pro/pre B-lymphocytes (B220(lo)/IgM(-)) immature (B220(lo)/IgM(+)) significantly decreased, while mature (B220(hi)/IgM(+)) remained unaffected. In contrast, B-lymphocytes, did affect or B-lymphocytes. The Gr-1(+) cells of lineage were depleted 50% only minimally Interestingly, monocytes (7/4(+)1A8(lo)) neutrophils (7/4(+)1A8(hi)) within this population affected by these PAHs. Monocytes whereas increased Although TNFalpha CYP1B1 implicated as essential mediators hypocellularity, similar induction mRNA BM suggests they limiting factors mediating different effects Given amounts reach when administered intraperitoneally, their differential on lineages probably stem from differences reactive metabolites such PAH quinones PAH-dihydrodiol-epoxides.

参考文章(69)
Brenda A Jensen, Rebecca J Leeman, Jennifer J Schlezinger, David H Sherr, Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study Environmental Health. ,vol. 2, pp. 16- 16 ,(2003) , 10.1186/1476-069X-2-16
H. Engelmann, H. Holtmann, C. Brakebusch, Y.S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, D. Wallach, Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. Journal of Biological Chemistry. ,vol. 265, pp. 14497- 14504 ,(1990) , 10.1016/S0021-9258(18)77330-4
Jack H. Dean, Immunotoxicology and immunopharmacology Raven Press. ,(1994)
Karah M. Lanier, Jean A. Grassman, Scott A. Masten, Nigel J. Walker, Diane L. Spencer, George W. Lucier, Xinping Yang, Thomas R. Sutter, Chris R. Miller, Quantitative Analysis of Constitutive and 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Cytochrome P450 1B1 Expression in Human Lymphocytes Cancer Epidemiology, Biomarkers & Prevention. ,vol. 8, pp. 139- 146 ,(1999)
Shawn M. Heidel, Karrie Holston, Jeroen T.M. Buters, Frank J. Gonzalez, Colin R. Jefcoate, Charles J. Czupyrynski, Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Molecular Pharmacology. ,vol. 56, pp. 1317- 1323 ,(1999) , 10.1124/MOL.56.6.1317
Koichi Yamaguchi, Raymond A Matulka, Alexander M Shneider, Paul Toselli, Anthony F Trombino, Shi Yang, Laurie J Hafer, Koren K Mann, Xiao-Jing Tao, Jonathan L Tilly, Richard I Near, David H Sherr, Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures. Toxicology and Applied Pharmacology. ,vol. 147, pp. 190- 203 ,(1997) , 10.1006/TAAP.1997.8263
A Dipple, Q A Khan, J E Page, I Pontén, J Szeliga, DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). International Journal of Oncology. ,vol. 14, pp. 103- 111 ,(1999) , 10.3892/IJO.14.1.103
Lynn H. Pottenger, Colin R. Jefcoate, Characterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2. Carcinogenesis. ,vol. 11, pp. 321- 327 ,(1990) , 10.1093/CARCIN/11.2.321